After Scioderm, Robert Ryan enters into second act
Robert Ryan will give it another go.
Ryan is the former co-founder and chief executive of Scioderm, Inc., a drug developer acquired in a deal that could ultimately be worth nearly $1 billion. At the end of 2015, Ryan left the company and now will launch a new drug development company not unlike his former one.
Scioderm, which was acquired by New Jersey-based Amicus Therapeutics, is developing a drug called Zorblisa that would treat Epidermolysis Bullosa (EB), a rare skin disease that affects infants… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 2, 2016 Category: Biotechnology Authors: Jason deBruyn Source Type: news
Epidermolysis Bullosa (EB)
Title: Epidermolysis Bullosa (EB)Category: Diseases and ConditionsCreated: 11/13/2015 12:00:00 AMLast Editorial Review: 11/13/2015 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - November 13, 2015 Category: Dermatology Source Type: news
Invuity launches Eikon LT retractor
Invuity (NSDQ:IVTY) said today it launched its Eikon LT illuminated retractor platform with tissue grips. The announcement was made at the American Society of Plastic Surgeon’s annual scientific conference.
The Eikon LT features atraumatic teeth on the distal tip of the retractor blade to aid plastic surgeons in creating breast pockets underneath pectoral muscle while minimizing tissue trauma, Boston-based Invuity said.
“With more women undergoing immediate breast reconstruction after breast cancer surgery, now more than ever, we need surgical technologies that enable us to operate with greater precision and s...
Source: Mass Device - October 16, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Cosmetic/Aesthetic Surgical Invuity Source Type: news
Invuity touts data from device-assisted mastectomy study
Invuity (NSDQ:IVTY) said today that data from a retrospective analysis of its Eikon illuminated retractor system during nipple-sparing mastectomies showed positive economic and clinical benefits.
Data from the study indicated a reduction in anasthesia time of 31 minutes, or 10%, a reduction in overall complication rates, a 70% reduction in epidermolysis and potential savings between $580 a $2,000, according to the San Francisco, Calif.-based company.
“We are pleased with these positive results, which show there are tangible and significant benefits to both patients and hospitals from the use of our Intelligent Photo...
Source: Mass Device - September 18, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Imaging Women's Health Invuity Source Type: news
Epidermolysis Bullosa vs. The California Stem Cell Program: Disease-a-week Challenge # 12
Try this. Take your right index finger and run it roughly across your left forearm. Nothing happens, right? You see the skin ripple, but it springs back like before. But if you had a skin condition called Epidermolysis Bullosa ( EB), even that small touch could leave a blister, and soon break apart, exposing raw flesh. When you first meet John Hudson Dilgen, (in the video "Boy with Butterfly Skin",) he is wearing what appear to be white sweats. He is smiling and talking, a beautiful regular little boy, the kind who would be running around like crazy at the school playground, and last to come in from recess. It takes a m...
Source: Science - The Huffington Post - August 14, 2015 Category: Science Source Type: news
Brody Curtis with skin condition epidermolysis bullos left in constant pain
WARNING: GRAPHIC CONTENT. Brody Curtis, four, of Charlestown, Indiana, suffers from epidermolysis bullosa. His body is covered with painful, blistering wounds that will never heal. (Source: the Mail online | Health)
Source: the Mail online | Health - August 13, 2015 Category: Consumer Health News Source Type: news
Dystrophic Epidermolysis Bullosa research boosted by record bike ride
Tom Davies, from Battersea, south west London, completed the 18,000-mile trek to boost a fund set up to research a cure for Recessive Dystrophic Epidermolysis Bullosa. (Source: the Mail online | Health)
Source: the Mail online | Health - August 8, 2015 Category: Consumer Health News Source Type: news
The Best Friend Ever? Meet A 9-Year-Old Bracelet Philanthropist
A 9-year-old girl with a big heart and nimble fingers raised $47,000 for a sick friend by selling rubber band bracelets on Facebook. Bethany Walker wanted to help her friend, Anne Marie Cox, of Benton Arkansas, who needed a saltwater therapy pool to ease the skin condition epidermolysis bullosa. “Any kind of friction or trauma to the skin causes the skin to blister and come off," Anne Marie's mother told ABC. "Being out in the summertime is just not going to happen." Public pools are off limits, too. The family failed to raise enough money to build a pool. So Bethany decided to raise money by selling ...
Source: Healthy Living - The Huffington Post - July 24, 2015 Category: Consumer Health News Source Type: news
Epidermolysis Bullosa Therapeutic Pipeline Assessment Review H1 2015...
RnRMarketResearch.com adds “Epidermolysis Bullosa - Pipeline Review, H1 2015” to its store. The report provides an overview of the Epidermolysis Bullosa’s therapeutic pipeline.(PRWeb June 25, 2015)Read the full story at http://www.prweb.com/releases/epidermolysis-bullosa/pipeline-review-h1-2015/prweb12808986.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 26, 2015 Category: Pharmaceuticals Source Type: news
Teenager with epidermolysis bullosa attends her high school prom
A team of doctors and nurses at a Cincinnati hospital came together to help get a teenage patient to the prom. Natasha Starkey, 19, suffers from a rare skin condition leaving her in constant pain. (Source: the Mail online | Health)
Source: the Mail online | Health - June 22, 2015 Category: Consumer Health News Source Type: news
The little girl who blisters so violently she can't even get a cuddle from mum: Rare condition means huge sores erupt at the slightest touch or movement
WARNING: GRAPHIC CONTENT. Tia Price, two, from Hertfordshire, suffers from from epidermolysis bullosa, which which causes her skin to blister in response to heat, light and touch. (Source: the Mail online | Health)
Source: the Mail online | Health - May 22, 2015 Category: Consumer Health News Source Type: news
Boy, 14, with fragile skin disorder Epidermolysis Bullosa speaks about battling condition
Born with Epidermolysis Bullosa Jonathan Pitre's body is covered with deep blistering wounds that will never heal. For the Ottawa teen, holding cutlery to eat is incredibly difficult. Bathing is excruciating. (Source: the Mail online | Health)
Source: the Mail online | Health - April 20, 2015 Category: Consumer Health News Source Type: news
What Causes Bullae?
Discussion
Bullae are fluid-filled epidermal lesions that are filled with serous or seropurulent fluid. They are > 1 cm in diameter and often easily rupture due to their thin walls. The differential diagnosis is different for bullae than for vesicular lesions with bullae being often more worrisome. However there is overlap and vesicular diseases can become large enough to be bullae. Drug toxicity and genetic problems are also more common in bullae whereas vesicles are more often caused by infectious diseases.
Potentially life threatening conditions such as toxic epidermal necrolysis syndrome, Stevens Johnson syndrome o...
Source: PediatricEducation.org - April 20, 2015 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Scioderm begins Phase III registration trial of Zorblisa to treat epidermolysis bullosa
US-based biopharmaceutical firm Scioderm has started a Phase III registration trial (SD-005) of its new topical therapy, Zorblisa (SD-101), to treat blisters and lesions in patients with Epidermolysis Bullosa (EB), a rare genetic connective tissue di… (Source: Drug Development Technology)
Source: Drug Development Technology - March 20, 2015 Category: Pharmaceuticals Source Type: news
Scioderm, Inc. Closes $20 Million Series B Round of Financing
Funds will be used to complete the clinical development program for ZorblisaTM
DURHAM, N.C., Dec. 18, 2014 -- (Healthcare Sales & Marketing Network) -- Scioderm, Inc., today announced it raised $20 million in a Series B financing round led by Redmile G... Biopharmaceuticals, Dermatology, Venture CapitalScioderm, Zorblisa, Epidermolysis Bullosa (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 18, 2014 Category: Pharmaceuticals Source Type: news
